Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?
- PMID: 25610593
- PMCID: PMC4278617
- DOI: 10.1086/678470
Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?
Abstract
Pulmonary arterial hypertension is a manifestation of a group of disorders leading to pulmonary vascular remodeling and increased pulmonary pressures. The right ventricular (RV) response to chronic pressure overload consists of myocardial remodeling, which is in many ways similar to that seen in left ventricular (LV) failure. Maladaptive myocardial remodeling often leads to intraventricular and interventricular dyssychrony, an observation that has led to cardiac resynchronization therapy (CRT) for LV failure. CRT has proven to be an effective treatment strategy in subsets of patients with LV failure resulting in improvement in LV function, heart failure symptoms, and survival. Current therapy for pulmonary arterial hypertension is based on decreasing pulmonary vascular resistance, and there is currently no effective therapy targeting the right ventricle or maladaptive ventricular remodeling in these patients. This review focuses on the RV response to chronic pressure overload, its effect on electromechanical coupling and synchrony, and how lessons learned from left ventricular cardiac resynchronization might be applied as therapy for RV dysfunction in the context of pulmonary arterial hypertension.
Keywords: cardiac resynchronization therapy; dyssynchrony; pulmonary arterial hypertension; pulmonary hypertension; right ventricular failure.
Figures
References
-
- McLaughlin VV, Archer SL, Badesch DB, Barst, RJ, Farber HW, Lindner JR, Mathier MA, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573–1619. - PubMed
-
- Van Wolferen SA, Marcus JT, Westerhof N, Spreeuwenberg MD, Marques KM, Bronzwaer JG, Henkens IR, et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 2008;29:120–127. - PubMed
-
- Li GR, Lau CP, Leung TK, Nattel S. Ionic abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles. Heart Rhythm 2004;1(4);460–468. - PubMed
-
- Ritchie M, Waggoner AD, Davila-Roman VG, Barzilai B, Trulock EP, Eisenberg PR. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. J Am Coll Cardiol 1993;22(4):1170–1174. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials